Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle-Reference-Cited by-同舟云学术

Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle

Published:2016-08 Issue:4 Volume:68 Page:692-702
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Ibarra-Lara Luz,Del Valle-Mondragón Leonardo,Soria-Castro Elizabeth,Torres-Narváez Juan C.,Pérez-Severiano Francisca,Sánchez-Aguilar María,Ramírez-Ortega Margarita,Cervantes-Pérez Luz G.,Pastelín-Hernández Gustavo S.,Oidor-Chan Víctor H.,Zarco-Olvera Gabriela,Sánchez-Mendoza Alicia

Funder

Consejo Nacional de Ciencia y Tecnología (CONACyT), Mexico

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference31 articles.

1. Left ventricular structure and risk of cardiovascular events: a framingham heart study cardiac magnetic resonance study;Tsao;J Am Heart Assoc,2015

2. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats;Zhang;Cardiovasc Res,2005

3. Nitrosative stress and pharmacological modulation of heart failure;Pacher;Trends Pharmacol Sci,2005

4. A mitochondrial superoxide theory for oxidative stress diseases and aging;Indo;J Clin Biochem Nutr,2015

5. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat;Banks;J Hypertens,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease;Medicinal Research Reviews;2023-04-29

2. Nitric Oxide-Releasing Platforms for Treating Cardiovascular Disease;Pharmaceutics;2022-06-25

3. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor;Pharmacology & Therapeutics;2021-05

4. Clofibrate, a Peroxisome Proliferator–Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride–Induced Toxicity;Biological Trace Element Research;2021-04-24

5. Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies;Hypertension Research;2021-03-10